Delivery Order SPE2DE24D0013-SPE2D625F1ED2
- Not listed
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a firm fixed-price delivery order valued at $1,843.36 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, issued on September 18, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. The delivery order will be performed in Sunnyvale and represents a continuation of Cepheid's ongoing provision of diagnostic equipment,...
- The Defense Logistics Agency has awarded a $1,277.84 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 2, 2025, with an ultimate completion date of June 9, 2025, carries no set-aside designation. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing, with a product portfolio centered on GeneXpert diagnostic systems, molecular...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a firm fixed-price delivery order valued at $3,708.00 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 12, 2025, carries no set-aside designation. This award represents a discrete delivery order under one of Cepheid's larger indefinite delivery vehicle contracts with the...
- The U.S. Defense Logistics Agency (under the Medical Supply Chain division) awarded a firm fixed-price delivery order valued at $8,820.00 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. The delivery order, issued on August 21, 2025, with an ultimate completion date of August 28, 2025, carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a continuation of Cepheid's ongoing...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,361.79 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of August 27, 2025, represents work to be performed at Cepheid's Sunnyvale facility. The contract carries no set-aside designation and is identified as delivery order XPRSMVP-10 under contract number...
- The U.S. Defense Department's Medical Supply Chain organization awarded a delivery order valued at $1,190.28 to Cepheid Inc. on August 14, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order does not utilize any set-aside designation and represents a discrete procurement under a broader federal vehicle. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, specializes in providing advanced diagnostic systems and test kits for...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $4,447.49 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 11, 2025. This delivery order carries no set-aside designation and will be performed in Sunnyvale, California. The award represents a continuation of Cepheid's established relationship with federal healthcare and defense...
- The Defense Logistics Agency awarded a delivery order to Cepheid Inc. valued at $26,312.70 under a firm fixed-price contract with an ultimate completion date of August 12, 2025. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing. This delivery order carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a...
- The Defense Logistics Agency has awarded a $13.6K delivery order (XPRS4PLEX-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, represents a continuation of the federal government's procurement of Cepheid's diagnostic testing capabilities. The award carries no set-aside designation and will be performed at Cepheid's...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1ED2Delivery Order
The Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $1,190.28 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California. This firm fixed-price delivery order, issued on June 6, 2025, with an ultimate completion date of June 23, 2025, carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic testing solutions to federal defense and healthcare agencies. The work will be performed in Sunnyvale, California. This delivery order falls within the scope of Cepheid's existing federal contract portfolio, which includes two significant Indefinite Delivery Vehicles with the Department of Veterans Affairs valued at approximately $35.3 million combined. Cepheid specializes in GeneXpert diagnostic systems, molecular reagents, and test kits for detecting infectious diseases including COVID-19, influenza, RSV, and other conditions requiring advanced molecular diagnostics. The company has consistently demonstrated its capacity to support federal healthcare systems through competitive firm fixed-price arrangements, and this award reflects continued reliance on Cepheid's diagnostic technologies across the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/6/25 |